CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
November 2016—Meridian Life Science released a new catalog that provides a detailed overview of the company’s cardiac and metabolic markers for assay development. Meridian’s top-performing cardiac and metabolic markers include Lp-PLA2, CRP, D-dimer, troponin, NT-proBNP, myoglobin, procalcitonin, FABP, PAPP-A, fibrinogen, sCD40L, MPO, NSE, and galectin-3.
Meridian also released a practical guide that provides a detailed overview on how blockers can be used to reduce nonspecific binding in immunoassays. Blockers are typically used in ELISA and lateral flow assays, paired monoclonal sandwich assays, competitive assays, and antigen capture (IgG/IgM) assays and work by blocking interfering proteins that can lead to false results. “Immunoassay Blocking Reagents: Practical Guide” features Meridian’s top-performing blockers, which include Tru Block (HAMA blocker), mouse IgG, IgM diluent, animal IgGs, IgG absorbent, and solid-phase blockers.
The catalogs can be downloaded from the company’s website at www.meridianlifescience.com.
Meridian Life Science, 901-382-8716